Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Quarterly results
CC transcript

ENDOCYTE INC (ECYT) Create: Alert

All | News | Filings
Date FiledTypeDescription
02/14/2019 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
12/31/2018 15-12B Form 15-12B - Securities registration termination [Section 12(b)]:
12/27/2018 EFFECT Form EFFECT - Notice of Effectiveness:
12/21/2018 4 MIDDLETON FRED A (Director) has filed a Form 4 on ENDOCYTE INC
Txns: Gifted 83,860 shares @ $0
Disposed/sold 110,189 shares @ $24, valued at $2.6M
Disposed/sold 3,300 shares @ $24, valued at $79.2k
Disposed/sold 1,017,304 shares @ $24, valued at $24.4M
Disposed/sold 1,212,413 shares @ $24, valued at $29.1M
Disposed/sold 267,491 shares @ $24, valued at $6.4M
Disposed/sold 249,148 shares @ $24, valued at $6M
Disposed/sold 162,170 shares @ $24, valued at $3.9M
Disposed/sold 113,315 shares @ $24, valued at $2.7M
Disposed/sold 100,828 shares @ $24, valued at $2.4M
Disposed/sold 10,049 shares @ $24, valued at $241.2k
12/21/2018 4 Machado Patrick (Director) has filed a Form 4 on ENDOCYTE INC
Txns: Disposed/sold 1,250 shares @ $24, valued at $30k
Disposed/sold 2,500 shares @ $24, valued at $60k
Disposed/sold 3,300 shares @ $24, valued at $79.2k
Disposed/sold 22,500 options to buy @ $4.2, valued at $94.5k
Disposed/sold 19,500 options to buy @ $10.81, valued at $210.8k
12/21/2018 4 McAvoy David R. (General Counsel) has filed a Form 4 on ENDOCYTE INC
Txns: Disposed/sold 2,119 shares @ $24, valued at $50.9k
Disposed/sold 23,750 shares @ $24, valued at $570k
Disposed/sold 37,500 options to buy @ $2.96, valued at $111k
12/21/2018 4 Leamon Christopher P (Vice President of Research) has filed a Form 4 on ENDOCYTE INC
Txns: Disposed/sold 164,256 shares @ $24, valued at $3.9M
Disposed/sold 4,375 shares @ $24, valued at $105k
Disposed/sold 13,125 shares @ $24, valued at $315k
Disposed/sold 20,000 shares @ $24, valued at $480k
Disposed/sold 22,500 shares @ $24, valued at $540k
Disposed/sold 27,500 options to buy @ $9.05, valued at $248.9k
Disposed/sold 59,996 options to buy @ $3.55, valued at $213k
Disposed/sold 70,000 options to buy @ $9.86, valued at $690.2k
Disposed/sold 45,000 options to buy @ $11.11, valued at $500k
Disposed/sold 52,498 options to buy @ $5.1, valued at $267.7k
Disposed/sold 52,498 options to buy @ $3.18, valued at $166.9k
12/21/2018 4 Armour Alison A. (Chief Medical Officer) has filed a Form 4 on ENDOCYTE INC
Txns: Gifted 10,500 shares @ $0
Gifted 10,500 shares @ $0
Disposed/sold 72,253 shares @ $24, valued at $1.7M
Disposed/sold 10,500 shares @ $24, valued at $252k
Disposed/sold 5,000 shares @ $24, valued at $120k
Disposed/sold 15,000 shares @ $24, valued at $360k
Disposed/sold 20,000 shares @ $24, valued at $480k
Disposed/sold 22,500 shares @ $24, valued at $540k
Disposed/sold 25,000 options to buy @ $5.16, valued at $129k
Disposed/sold 45,788 options to buy @ $3.18, valued at $145.6k
Disposed/sold 39,999 options to buy @ $2.16, valued at $86.4k
12/21/2018 4 Parker Katherine (VP of Human Resources) has filed a Form 4 on ENDOCYTE INC
Txns: Gifted 8,229 shares @ $0
Disposed/sold 22,797 shares @ $24, valued at $547.1k
Disposed/sold 3,125 shares @ $24, valued at $75k
Disposed/sold 9,375 shares @ $24, valued at $225k
Disposed/sold 15,000 shares @ $24, valued at $360k
Disposed/sold 12,500 shares @ $24, valued at $300k
Disposed/sold 1,200 shares @ $24, valued at $28.8k
Disposed/sold 19,000 options to buy @ $11.47, valued at $217.9k
Disposed/sold 60,000 options to buy @ $5.1, valued at $306k
Disposed/sold 37,500 options to buy @ $3.18, valued at $119.3k
Disposed/sold 25,000 options to buy @ $2.16, valued at $54k
12/21/2018 4 Russell Lesley (Director) has filed a Form 4 on ENDOCYTE INC
Txns: Disposed/sold 7,800 shares @ $24, valued at $187.2k
Disposed/sold 3,300 shares @ $24, valued at $79.2k
Disposed/sold 28,000 options to buy @ $9.63, valued at $269.6k
Disposed/sold 14,000 options to buy @ $12.94, valued at $181.2k
Disposed/sold 14,000 options to buy @ $6.69, valued at $93.7k
Disposed/sold 13,500 options to buy @ $6.02, valued at $81.3k
Disposed/sold 13,500 options to buy @ $3.35, valued at $45.2k
Disposed/sold 19,500 options to buy @ $2.27, valued at $44.3k
Disposed/sold 19,500 options to buy @ $10.81, valued at $210.8k
12/21/2018 4 Chelius Erik C. (Vice President CMC) has filed a Form 4 on ENDOCYTE INC
Txns: Disposed/sold 15,848 shares @ $24, valued at $380.4k
Disposed/sold 3,516 shares @ $24, valued at $84.4k
Disposed/sold 4,281 shares @ $24, valued at $102.7k
Disposed/sold 10,000 shares @ $24, valued at $240k
Disposed/sold 16,250 shares @ $24, valued at $390k
Disposed/sold 14,000 options to buy @ $3.64, valued at $51k
Disposed/sold 15,500 options to buy @ $9.86, valued at $152.8k
Disposed/sold 10,850 options to buy @ $11.11, valued at $120.5k
Disposed/sold 11,568 options to buy @ $5.1, valued at $59k
Disposed/sold 14,062 options to buy @ $3.18, valued at $44.7k
Disposed/sold 11,413 options to buy @ $2.16, valued at $24.7k
12/21/2018 4 APLIN JOHN C (Director) has filed a Form 4 on ENDOCYTE INC
Txns: Disposed/sold 28,863 shares @ $24, valued at $692.7k
Disposed/sold 3,300 shares @ $24, valued at $79.2k
Disposed/sold 15,706 options to buy @ $6, valued at $94.2k
Disposed/sold 10,000 options to buy @ $11.8, valued at $118k
Disposed/sold 10,000 options to buy @ $6.43, valued at $64.3k
Disposed/sold 14,000 options to buy @ $12.94, valued at $181.2k
Disposed/sold 14,000 options to buy @ $6.69, valued at $93.7k
Disposed/sold 13,500 options to buy @ $6.02, valued at $81.3k
Disposed/sold 13,500 options to buy @ $3.35, valued at $45.2k
Disposed/sold 19,500 options to buy @ $2.27, valued at $44.3k
Disposed/sold 19,500 options to buy @ $10.81, valued at $210.8k
12/21/2018 4 Taylor Beth (VP Finance & Chief Acctg Off) has filed a Form 4 on ENDOCYTE INC
Txns: Disposed/sold 59,509 shares @ $24, valued at $1.4M
Disposed/sold 1,250 shares @ $24, valued at $30k
Disposed/sold 1,875 shares @ $24, valued at $45k
Disposed/sold 7,500 shares @ $24, valued at $180k
Disposed/sold 15,000 shares @ $24, valued at $360k
Disposed/sold 12,500 shares @ $24, valued at $300k
Disposed/sold 23,560 options to buy @ $7.41, valued at $174.6k
Disposed/sold 9,132 options to buy @ $9.86, valued at $90k
Disposed/sold 10,850 options to buy @ $11.11, valued at $120.5k
Disposed/sold 3,750 options to buy @ $3.18, valued at $11.9k
Disposed/sold 12,969 options to buy @ $3.21, valued at $41.6k
12/21/2018 4 GODDARD COLIN (Director) has filed a Form 4 on ENDOCYTE INC
Txns: Disposed/sold 7,800 shares @ $24, valued at $187.2k
Disposed/sold 3,300 shares @ $24, valued at $79.2k
Disposed/sold 28,000 options to buy @ $10.37, valued at $290.4k
Disposed/sold 14,000 options to buy @ $6.69, valued at $93.7k
Disposed/sold 13,500 options to buy @ $6.02, valued at $81.3k
Disposed/sold 13,500 options to buy @ $3.35, valued at $45.2k
Disposed/sold 19,500 options to buy @ $2.27, valued at $44.3k
Disposed/sold 19,500 options to buy @ $10.81, valued at $210.8k
12/21/2018 4 Svoronos Dawn (Director) has filed a Form 4 on ENDOCYTE INC
Txns: Disposed/sold 3,750 shares @ $24, valued at $90k
Disposed/sold 3,300 shares @ $24, valued at $79.2k
Disposed/sold 22,500 options to buy @ $10.81, valued at $243.2k
Disposed/sold 19,500 options to buy @ $10.81, valued at $210.8k
12/21/2018 4 KOZIN MARC D (Director) has filed a Form 4 on ENDOCYTE INC
Txns: Disposed/sold 7,800 shares @ $24, valued at $187.2k
Disposed/sold 3,300 shares @ $24, valued at $79.2k
Disposed/sold 20,000 options to buy @ $7.71, valued at $154.2k
Disposed/sold 14,000 options to buy @ $12.94, valued at $181.2k
Disposed/sold 14,000 options to buy @ $6.69, valued at $93.7k
Disposed/sold 13,500 options to buy @ $6.02, valued at $81.3k
Disposed/sold 13,500 options to buy @ $3.35, valued at $45.2k
Disposed/sold 19,500 options to buy @ $2.27, valued at $44.3k
Disposed/sold 19,500 options to buy @ $10.81, valued at $210.8k
12/21/2018 4 Sherman Michael A. (President and CEO) has filed a Form 4 on ENDOCYTE INC
Txns: Disposed/sold 243,739 shares @ $24, valued at $5.8M
Disposed/sold 19,919 shares @ $24, valued at $478.1k
Disposed/sold 7,188 shares @ $24, valued at $172.5k
Disposed/sold 5,000 shares @ $24, valued at $120k
Disposed/sold 23,438 shares @ $24, valued at $562.5k
Disposed/sold 62,500 shares @ $24, valued at $1.5M
Disposed/sold 37,500 shares @ $24, valued at $900k
Disposed/sold 20,800 options to buy @ $9.05, valued at $188.2k
Disposed/sold 74,998 options to buy @ $3.55, valued at $266.2k
Disposed/sold 58,719 options to buy @ $9.86, valued at $579k
Disposed/sold 36,000 options to buy @ $11.11, valued at $400k
12/21/2018 4 Low Philip S (Chief Science Officer) has filed a Form 4 on ENDOCYTE INC
Txns: Disposed/sold 349,944 shares @ $24, valued at $8.4M
Disposed/sold 132,473 shares @ $24, valued at $3.2M
Disposed/sold 4,375 shares @ $24, valued at $105k
Disposed/sold 13,125 shares @ $24, valued at $315k
Disposed/sold 20,000 shares @ $24, valued at $480k
Disposed/sold 22,500 shares @ $24, valued at $540k
Disposed/sold 13,570 options to buy @ $3.82, valued at $51.8k
Disposed/sold 8,560 options to buy @ $9.05, valued at $77.5k
Disposed/sold 17,950 options to buy @ $11.8, valued at $211.8k
Disposed/sold 59,996 options to buy @ $3.55, valued at $213k
Disposed/sold 56,918 options to buy @ $9.86, valued at $561.2k
12/21/2018 4 Andriole Michael T. (CFO) has filed a Form 4 on ENDOCYTE INC
Txns: Disposed/sold 52,582 shares @ $24, valued at $1.3M
Disposed/sold 37,500 shares @ $24, valued at $900k
Disposed/sold 25,000 shares @ $24, valued at $600k
Disposed/sold 75,000 options to buy @ $2.22, valued at $166.5k
Disposed/sold 50,000 options to buy @ $3.01, valued at $150.5k
12/21/2018 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
12/21/2018 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
12/21/2018 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
12/21/2018 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
12/21/2018 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
12/21/2018 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
12/21/2018 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
12/21/2018 POSASR Form POSASR - Post-effective Amendment to an automatic shelf registration statement:
12/21/2018 8-K Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Sta...
Docs: "Amended and Restated Certificate of Incorporation of Endocyte, Inc., effective December 21, 2018",
"Amended and Restated Bylaws of Endocyte, Inc., effective December 21, 2018",
"Form of Amendment to Change in Control and Severance Agreement"
12/21/2018 25-NSE Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities:
12/20/2018 POS AM Form POS AM - Post-Effective amendments for registration statement:
12/19/2018 4 Taylor Beth (VP Finance & Chief Acctg Offcr) has filed a Form 4 on ENDOCYTE INC
Txns: Gifted 2,500 shares @ $0
Gifted 1,250 shares @ $0
Gifted 3,186 shares @ $0
Gifted 1,250 shares @ $0
Exercised 16,073 options to buy @ $3.55, valued at $57.1k
Exercised 5,500 options to buy @ $9.86, valued at $54.2k
Exercised 9,000 options to buy @ $5.1, valued at $45.9k
Exercised 3,750 options to buy @ $3.18, valued at $11.9k
Exercised 9,531 options to buy @ $3.21, valued at $30.6k
Exercised 5,000 options to buy @ $2.16, valued at $10.8k
12/19/2018 4 Leamon Christopher P (Vice President of Research) has filed a Form 4 on ENDOCYTE INC
Txns: Exercised 20,000 options to buy @ $2.54, valued at $50.8k
Exercised 26,177 options to buy @ $3.82, valued at $100k
Exercised 13,089 options to buy @ $7.49, valued at $98k
Exercised 22,500 options to buy @ $9.05, valued at $203.6k
Exercised 20,004 options to buy @ $3.55, valued at $71k
Exercised 2 options to buy @ $5.1, valued at $10.2
Exercised 2 options to buy @ $3.18, valued at $6.4
12/19/2018 4 Andriole Michael T. (CFO) has filed a Form 4 on ENDOCYTE INC
Txns: Gifted 4,500 shares @ $0
Exercised 25,000 options to buy @ $2.22, valued at $55.5k
12/19/2018 4 Armour Alison A. (Chief Medical Officer) has filed a Form 4 on ENDOCYTE INC
Txns: Exercised 35,000 options to buy @ $5.16, valued at $180.6k
Exercised 14,212 options to buy @ $3.18, valued at $45.2k
Exercised 1 options to buy @ $2.16, valued at $2.2
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy